TP53 and renal cell carcinoma: SLC7A11 also plays an important role in RCC development; both p53 and BRCA1-associated protein 1 (BAP1) can inhibit SLC7A11 expression, thus promoting ferroptosis to suppress RCC development [23,24,25].